Krishna Institute of Medical Sciences (KIMS) — deviation variation

📢 Key Event
KIMS reports zero fund utilization deviation for QIP quarter

💡 Investor Takeaway
Shareholders see no misuse of capital, maintaining trust in capital allocation discipline.

KIMS confirmed no deviation in fund utilization for the quarter ended June 30, 2026, from its Qualified Institutional Placement. The company raised Rs. 1500 crores on June 19, 2026, and allocated proceeds across repayment, subsidiary investments, and general corporate purposes without any variance. The Audit Committee validated zero deviation, with no auditor comments.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KIMS ✨ Ask AI About This

About Krishna Institute of Medical Sciences Limited (KIMS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹30,476.58 Cr P/E: 80.3

View full KIMS stock details →

📡 Get AI alerts when KIMS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KIMS — Free

💡 Ask AI about this filing

"How does this compare to peers' QIP fund usage patterns?" "What is the timeline for the next capital raise?" "How will unused funds affect future dividend plans?"

Ask AI Free →

📊 More KIMS filings

See all KIMS filings →

🔥 Also filed on 3 August 2026

TEXRAIL Texmaco Rail & Engineering Limited Financial Results UNITDSPR United Spirits Limited Announcement TENNIND Tenneco Clean Air India Limited Annual Report NAZARA Nazara Technologies Limited Financial Results NOIDATOLL Noida Toll Bridge Company Limited Financial Results RBA Restaurant Brands Asia Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KIMS files new disclosures

Track KIMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.